Business ❯ Biotechnology

Pharmaceutical Companies

Moderna Biogen Clinical Research Clinical Research Organizations Drug Testing Sarepta Therapeutics Drug Development Public Offerings Sinovant Sciences Market Development REGENXBIO UniQure Vaccine Development Priovant Therapeutics Ocugen, Inc. Metabolic Health Capricor Therapeutics BBOT Executive Leadership Bavarian Nordic Market Analysis Regulatory Affairs Roivant Sciences Market Performance Covid-19 Vaccine Market

Avalo Therapeutics Reports Positive Phase 2 HS Results, Prices $375 Million Offering

The twin updates position Avalo to begin Phase 3 testing of a potential new treatment for hidradenitis suppurativa.

FDA Approves Higher‑Dose Spinraza Regimen for Spinal Muscular Atrophy

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Ocugen Completes Phase III Enrollment for OCU400 and Targets Q3 2026 Rolling BLA

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy Application

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure